Has Mark Emig, MD received payments from drug or device companies?

Yes. Drug and device makers reported $877 in general payments to Mark Emig, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Emig, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Emig, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Emig, MD

Ophthalmology · Omaha, NENPI 1235111212

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Alcon at 42.2% of the total. Reporting peaked in 2019 at $348 and has fallen 94.3% since, to $20 in 2025.

$877in general payments, 2019–2025

Across 9 payments — averaging $97.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$370
Genentech USA, Inc.$245
Novartis$229
Rxsight Inc$20
Apellis Pharmaceuticals, Inc.$14

What the payments were for

Food & beverage$877100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	3	$370
Genentech USA, Inc.	2	$245
Novartis	2	$229
Rxsight Inc	1	$20
Apellis Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$877 in reported general payments places this provider in the 55th percentile of 105 ophthalmology providers in Nebraska.

See all ophthalmology providers in Nebraska →

Medicare billing

Part B allowed, 2024

$3,816,815

Medicare patients

1,165

Services billed

48,915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	138	$6,196
CombiganBrimonidine Tartrate/Timolol	21	$5,669
Cyclosporine	14	$4,452
Latanoprost	314	$2,996
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	26	$2,847
Bromfenac Sodium	12	$2,158
MoxifloxacinMoxifloxacin Hcl	36	$985
Timolol Maleate	118	$975
Brimonidine Tartrate	37	$733
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	28	$463
ValacyclovirValacyclovir Hcl	13	$282
Dorzolamide Hcl	19	$273

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Omaha

Brandon BaartmanOmaha$226K
Ronald KruegerOmaha$224K
Lorraine ProvencherOmaha$220K
Lance KuglerOmaha$41K
Rao ChunduryOmaha$14K
Shane HavensOmaha$6K
Brandon MenkeOmaha$6K
Sao LiuOmaha$5K
Michael HalstedOmaha$4K
Thomas HejkalOmaha$4K

See the full list for Nebraska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →